정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1353 | Recruiting | FREEDOM COVID-19 Anticoagulation Strategy | SARS-CoV-2 | Drug: Enoxaparin Drug: Apixaban |
Phase 4 | Valentin Fuster | OTHER | 3600 | All | 18 Years | Icahn School of Medicine at Mount Sinai, New York, New York, United States Instituto do Coracao - INCOR, Sao Paulo, Brazil Instituto Prevent Senior - IPS, Sao Paulo, Brazil Clinica de la Costa, Barranquilla, Colombia Clinica Shaio, Bogota, Colombia Fundacion Cardioinfantil, Bogota, Colombia Fundacion Oftalmologica de Santander - Foscal, Bucaramanga, Colombia Centro Medico Imbanaco, Cali, Colombia CardioVid, Medellin, Colombia Eternal Heart Care Centre and Research Ins Pvt Ltd., Jaipur, India Jaipur National University, Jaipur, India Sawai Mann Singh Hospital, Jaipur, India Jaslok Hospital & Research Center, Mumbai, India Saifee Hospital, Mumbai, India Sengupta Hospital & Research Institute, Nagpur, India D Y Patil University School of Medicine & D Y Patil Hospital, Navi Mumbai, India Hospital Cardiologica Aguascalientes, Aguascalientes, Mexico Centro Medico Nacional 20 de Noviembre, Mexico City, Mexico Christus Muguerza Hospital Alta Especialidad, Monterrey, Mexico Centro de Estudios Clinicos de Queretaro S.C., Santiago de Queretaro, Mexico Centro Medico Hospital del Prado, Tijuana, Mexico |
| 1352 | Completed | Full Anticoagulation Versus Prophylaxis in COVID-19: COALIZAO ACTION Trial | Coronavirus Infection | Drug: Group 1: Rivaroxaban 20mg/d followed by enoxaparin/unfractionated heparin when needed Drug: Group 2: control group with enoxaparin 40mg/d |
Phase 4 | Brazilian Clinical Research Institute, Hospital Israelita Albert Einstein, Hospital do Coracao, Hospital Sirio-Libanes, Hospital Moinhos de Vento, Hospital Alemao Oswaldo Cruz, Beneficencia Portuguesa de Sao Paulo, Brazilian Research In Intensive Care Network | OTHER | 615 | All | 18 Years | Centro de Estudos Clinicos do Hospital Cardio Pulmonar, Salvador, Bahia, Brazil Instituto de Ensino e Pesquisa do Hospital da Bahia, Salvador, Bahia, Brazil Santa Casa de Misericordia da Bahia - Hospital Santa Izabel, Salvador, Bahia, Brazil Hospital Maternidade Sao Vicente de Paulo, Barbalha, Ceara, Brazil Centro de Ensino e Aperfeicoamento em Pesquisa - CEAP, Serra, Espirito Santo, Brazil Centro de Pesquisas Cardiologicas de Goiania do Hospital das Clinicas (UFG), Goiania, Goias, Brazil Hospital Vera Cruz, Belo Horizonte, Minas Gerais, Brazil Nucleo de Ciencias de Saude - Unidade de Pesquisa - Hospital Felicio Rocho, Belo Horizonte, Minas Gerais, Brazil Centro de Pesquisa Clinica do Hospital de Clinicas da Universidade Federal de Uberlandia, Uberlandia, Minas Gerais, Brazil Hospital Universitario da Universidade Estadual de Londrina, Londrina, Parana, Brazil Hospital Agamenon Magalhaes, Recife, Pernambuco, Brazil Real Hospital Portugues de Beneficencia em Pernambuco, Recife, Pernambuco, Brazil Hospital Moinhos de Vento, Porto Alegre, Rio Grande Do Sul, Brazil Hospital Nereu Ramos, Florianopolis, Santa Catarina, Brazil Instituto Baia Sul de Ensino E Pesquisa Dr. Irineu May Brodbeck / Hospital Baia Sul, Florianopolis, Santa Catarina, Brazil Hospital Regional Hans Dieter Schmidt, Joinville, Santa Catarina, Brazil Hospital de Amor de Barretos - (Pio XII), Barretos, Sao Paulo, Brazil Unidade de Pesquisa Clinica da Faculdade de Medicina de Botucatu - Unesp, Botucatu, Sao Paulo, Brazil Hospital Universitario Sao Francisco de Assis, Braganca Paulista, Sao Paulo, Brazil Hospital Regional do Litoral Norte, Caraguatatuba, Sao Paulo, Brazil Hospital Regional de Registro, Registro, Sao Paulo, Brazil Praxis Pesquisa Medica, Santo Andre, Sao Paulo, Brazil Centro Integrado de Pesquisa (CIP) - Hospital de Base de Rio Preto, Sao Jose Do Rio Preto, Sao Paulo, Brazil Hospital Regional de Sao Jose dos Campos, Sao Jose Dos Campos, Sao Paulo, Brazil Santa Casa de Misericordia de Votuporanga, Votuporanga, Sao Paulo, Brazil Hospital Naval Marcilio Dias, Rio de Janeiro, Brazil BP - A Beneficencia Portuguesa de Sao Paulo, Sao Paulo, Brazil Hcor - Hospital do Coracao, Sao Paulo, Brazil Hospital Israelita Albert Einstein, Sao Paulo, Brazil Hospital Moriah, Sao Paulo, Brazil Hospital Samaritano Paulista, Sao Paulo, Brazil Hospital Santa Paula, Sao Paulo, Brazil Hospital Sao Paulo, Sao Paulo, Brazil Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil Instituto de Assistencia Medica ao Servidor Publico Estadual de S. Paulo, Sao Paulo, Brazil Instituto do Coracao do Hospital das Clinicas da Faculdade de Medicina da USP-InCor-HCFMUSP, Sao Paulo, Brazil |
| 1351 | Completed | Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 Patients | COVID | Drug: Enoxaparin Drug: Prophylactic/Intermediate Dose Enoxaparin |
Phase 3 | Northwell Health | OTHER | 257 | All | 18 Years | Beth Israel Newark, Newark, New Jersey, United States Southside Hospital, Bay Shore, New York, United States Huntington Hospital, Huntington, New York, United States Lenox Hill Hospital, New York, New York, United States Long Island Jewish Medical Center, Queens, New York, United States Staten Island University Hospital, Staten Island, New York, United States |
| 1350 | Recruiting | Furosemide as Supportive Therapy for COVID-19 Respiratory Failure | Respiratory Failure | Drug: Nebulized Furosemide Drug: Nebulized Saline |
Phase 3 | Queen's University, University Health Network, Toronto | OTHER | 640 | All | 18 Years ~ 100 Years | University of Alberta, Edmonton, Alberta, Canada Dalhousie University, Halifax, Nova Scotia, Canada Kingston Health Sciences Center, Kingston, Ontario, Canada Hopital Maisonneuve-Rosemont, Montreal, Quebec, Canada |
| 1349 | Completed | FX06 to Rescue Acute Respiratory Distress Syndrome During Covid-19 Pneumonia | Pneumonia | Drug: FX06 Drug: Placebo of FX06 |
Phase 2 | Assistance Publique - Hopitaux de Paris | OTHER | 50 | All | 18 Years | Service de Medecine Intensive Reanimation - CHU Angers, Angers, France Service de Medecine Intensive Reanimation - CHI de Poissy, Chambourcy, France Hopital Pitie Salpetriere, Paris, France |
| 1348 | Withdrawn | Gargling and Nasal Rinses to Reduce Oro- and Nasopharyngeal Viral Load in Patients With COVID-19 | COVID-19 | Drug: Saline oral/nasal rinse Drug: 0.5% Povidone/Iodine oral/nasal rinse Drug: 0.12% Chlorhexidine oral/nasal rinse |
Phase 2 | NYU Langone Health | OTHER | 0 | All | 18 Years ~ 79 Years | NYU Langone Health, New York, New York, United States |
| 1347 | Completed | Glenzocimab in SARS-Cov-2 Acute Respiratory DistrEss syNdrome Related to COVID-19 | ARDS | Drug: glenzocimab Drug: Placebo |
Phase 2 | Acticor Biotech | INDUSTRY | 60 | All | 18 Years ~ 80 Years | Hopital de Hautepierre, Strasbourg, France |
